Crossref

1. Exploring breast and prostate cancer RNA-seq derived radiosensitivity with the Genomic Adjusted Radiation Dose (GARD) model

- Ben Nolan

- Brian O’Sullivan

- Aaron Golden

2. In Curative Stereotactic Body Radiation Therapy for Prostate Cancer, There Is a High Possibility That 45 Gy in Five Fractions Will Not Be Tolerated without a Hydrogel Spacer

- Subaru Sawayanagi

- Hideomi Yamashita

- Mami Ogita

- Taketo Kawai

- Yusuke Sato

- Haruki Kume

3. Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer

- Subaru Sawayanagi

- Hideomi Yamashita

- Mami Ogita

- Ryosuke Takenaka

- Yuki Nozawa

- Yuichi Watanabe

- Toshikazu Imae

- Osamu Abe

4. Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer

- Marcello Serra

- Gianluca Ametrano

- Valentina Borzillo

- Maria Quarto

- Matteo Muto

- Rossella Di Franco

- Savino Federica

- Filomena Loffredo

- Muto Paolo

5. The role of the spatially fractionated radiation therapy in the management of advanced bulky tumors

- Farshid Mahmoudi

- Daryoush Shahbazi-Gahrouei

- Nahid Chegeni

6. Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer

- Wolfgang Lilleby

- Amar Kishan

- Hans Geinitz